IndraLab
Statements
Vortioxetine inhibits FOS. 2 / 2
|
2
reach
"The Tukey’s HSD multiple comparisons test showed that diabetic rats had significantly higher densities of c-Fos immunoreactive cells than those of the control group (p < 0.001), and vortioxetine treatment at both doses decreased these enhanced densities of c-Fos immunopositive cells [F (3, 28) = 124.1; p < 0.001]."